<DOC>
	<DOC>NCT00709553</DOC>
	<brief_summary>The purpose of the study is to to assess the effect of multiple oral doses of ZD4054 (Zibotentan) on the pharmacokinetics of a CYP450 3A Probe (midazolam) in healthy male subjects.</brief_summary>
	<brief_title>Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)</brief_title>
	<detailed_description />
	<mesh_term>Midazolam</mesh_term>
	<criteria>BMI between 18 and 30 kg/m2 Medical and surgical history and physical examination without any clinically significant findings Normal resting ECG with QTcB interval &lt;450ms Definite or suspected personal history or family history of hypersensitivity to drugs that are endothelin antagonists; ie, ambrisentan, artrasentan, sitaxsetan and bosentan Healthy volunteer has a known hypersensitivity to midazolam or any of the excipients of the midazolam tablet Medical diagnosis of migraine with an attack during the 12 months prior to Screening</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>ZD4054</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>